Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000864792 | SCV001005650 | likely benign | Bardet-Biedl syndrome | 2023-10-27 | criteria provided, single submitter | clinical testing | |
Natera, |
RCV001273909 | SCV001457503 | uncertain significance | Bardet-Biedl syndrome 2 | 2020-01-17 | no assertion criteria provided | clinical testing | |
Prevention |
RCV004733069 | SCV005367308 | likely benign | BBS2-related disorder | 2024-04-09 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |